The Origins: Timothy Leary and the 1964 Framework

The concept of "set and setting" was first formally articulated by Timothy Leary, Richard Alpert (later Ram Dass), and Ralph Metzner in their 1964 guide "The Psychedelic Experience," developed partly from the I Ching and Buddhist texts but drawing directly from their research at Harvard and Millbrook. Leary's central insight was that psilocybin and LSD were not drugs with fixed effects like anesthetics or stimulants — their effects were profoundly shaped by context. The same molecule in the same dose produced radically different experiences depending on who took it, why they took it, and where.

This was not merely a philosophical observation but one grounded in what Leary and colleagues observed across hundreds of sessions. Participants who entered with fear had frightening experiences. Those who entered with curiosity and support had remarkable ones. The pharmacology was the same. The non-pharmacological context was the differentiating variable.

Sixty years later, this observation has been confirmed by controlled clinical research and given a neurobiological explanation. Set and setting is no longer mysticism — it is established neuroscience.

The Neuroscience: Why Set and Setting Matter So Much

The REBUS Model (Carhart-Harris and Friston)

In 2019, Robin Carhart-Harris and Karl Friston (Imperial College London) published the REBUS (Relaxed Beliefs Under Psychedelics) model in the journal Pharmacological Reviews. REBUS draws on Karl Friston's Predictive Coding framework — the theory that the brain is fundamentally a prediction machine, constantly comparing incoming sensory information to prior expectations and suppressing information that matches predictions.

Under normal conditions, high-level beliefs and expectations (encoded in cortical hierarchies) dominate incoming sensory information. What we perceive is heavily filtered by what we expect. Psilocybin, REBUS proposes, suppresses this top-down predictive filtering — particularly in the default mode network (DMN). This "flattening" of the cortical hierarchy means lower-level sensory and emotional signals are given unusual weight, producing altered perception, ego dissolution at high doses, and heightened emotional sensitivity.

The critical implication for set and setting: if top-down predictive suppression is reduced, the brain becomes more responsive to incoming input from both the internal state (set) and the external environment (setting). Fear from the internal state flows through with less inhibition. Anxiety from the environment is amplified rather than filtered. Conversely, a calm internal state and a safe, beautiful environment are processed with more emotional impact than they would be in ordinary waking consciousness.

REBUS explains at a mechanistic level why set and setting can account for more outcome variability than dose. The drug loosens the filter. What passes through the loosened filter is determined by set and setting.

Research Confirming Set as a Predictor of Mystical Experience

The Griffiths protocol at Johns Hopkins — the series of studies that restarted modern psilocybin research from 2006 onward — found systematic evidence that pre-session mindset factors predicted the probability and depth of mystical-type experiences. Participants who scored higher on measures of spiritual openness and positive expectancy before sessions were significantly more likely to have complete mystical experiences (as measured by the Mystical Experience Questionnaire). Since mystical experience scores correlate with therapeutic outcomes (antidepressant effects, cessation of addiction behavior), this finding has direct clinical implications.

A 2022 study published in the Journal of Psychopharmacology examined pre-session expectation, absorption (trait tendency toward immersive attention), and emotional valence as predictors of psilocybin session outcomes across a large naturalistic sample. Expectation valence (whether participants anticipated positive or negative experiences) was one of the strongest predictors of actual session valence. The pharmacology was held roughly constant; the mindset variable predicted experience quality.

SET: Mindset Components in Detail

Set encompasses all internal psychological factors present at the time of the experience. These can be thought of in five domains:

1. Intentions

Intention is the explicit purpose you bring to a session. Intentions serve as anchors when the experience becomes disorienting and as organizing frameworks for integration afterward. Common intentions include: healing a specific emotional wound, exploring creativity, addressing a particular pattern of behavior, spiritual inquiry, or simply curiosity and openness. The most effective intentions tend to be formulated as questions rather than demands — "I am open to understanding what is holding me back" rather than "I will heal my depression today." Outcome-attached intentions frequently create resistance when the experience goes its own direction, which it often does.

2. Expectations

Expectations are often unconscious or partly formed. They can be shaped by media portrayals (both positive and negative), prior experience reports, fears absorbed from anti-drug messaging, or hopes shaped by therapeutic framing. Unrealistic positive expectations create their own problems — sessions that are merely interesting rather than life-changing may feel like failures. Negative expectations create anxiety that tends to become self-fulfilling. The preparation goal is not to have no expectations but to hold expectations lightly.

3. Emotional State

Emotional state on the day of a session matters more than general baseline wellbeing. An acute episode of anxiety, grief, or interpersonal conflict adds emotional material that psilocybin will tend to surface and amplify. This is neither inherently bad nor good — sometimes working through acute emotional material in a supported psilocybin session produces significant healing. But without preparation and support, acute distress on the day of a session increases the probability of a difficult experience. Most experienced practitioners recommend postponing if you are in acute emotional crisis, unless you have experienced therapeutic support available.

4. Mental Health Baseline

Long-term mental health baseline differs from acute state. Certain baseline conditions create genuine contraindications: personal or first-degree family history of psychosis, schizophrenia, or schizoid personality disorder; bipolar I disorder; and borderline personality disorder in some therapeutic models. These are not absolute prohibitions in all contexts — some clinical research has explored psilocybin in complex presentations — but they require professional clinical oversight and substantially altered protocols. Self-directed use in these populations carries meaningfully higher risk. This is not stigma; it is pharmacology. Psilocybin's action on dopaminergic and serotonergic systems in vulnerable individuals can precipitate psychotic episodes.

5. Prior Experience and Personality Factors

Prior psychedelic experience is a relevant set factor. First experiences carry more uncertainty simply because you do not know how you respond. Personality factors also predict experience quality: absorption (the tendency toward deep, immersive attention) consistently predicts richer and more mystical experiences. Trait anxiety predicts more difficult ones. Openness to experience (Big Five personality dimension) correlates with positive responses. None of these are fixed — preparation can modify effective set even for people with high trait anxiety or low prior experience.

SETTING: Environment Components in Detail

Physical Environment

The physical space should be private, familiar (or made familiar through prior visits), and physically safe. "Safe" means: no trip hazards, no access to a car or other dangerous machinery, no sharp implements in accessible areas, comfortable surfaces to lie on, and access to water and food. Temperature should be controllable — people often move between feeling hot and cold during experiences. Access to outdoor space is a meaningful enhancement; natural environments tend to be experienced as particularly rich under psilocybin, but outdoor sessions require additional safety planning (no traffic, no people who might react poorly to encountering someone in an altered state).

People Present

The presence and quality of people during a session may be the single most impactful setting variable. Options include: solo (highest risk, not recommended for inexperienced users); with a sitter (a sober, trusted person present for safety who does not guide the experience); with a guide or facilitator (someone with experience, who actively supports the session and helps with integration); and in a clinical setting with trained therapists (as in formal trials). Each step in this list adds safety and therapeutic potential. The relationship with the person present is critical — a sitter you don't fully trust introduces the anxiety of scrutiny at a moment when vulnerability is high.

Facilitator Relationship

In guided or therapeutic contexts, the pre-session relationship with the guide or therapist strongly predicts outcomes. This is called the "therapeutic alliance" in clinical research, and it is one of the most replicated predictors of positive outcomes across all psychotherapy modalities. In psychedelic sessions, the importance is amplified because the state involves heightened vulnerability and decreased rational evaluation capacity. Building genuine trust and rapport with a facilitator or guide before a session is not optional — it is part of the intervention itself.

Cultural Context

Psilocybin has been used in ceremonial contexts by indigenous communities in Mesoamerica and elsewhere for centuries. These contexts provide specific cultural frameworks — songs (icaros), ritual structure, community presence — that function as setting elements shaping how experiences are interpreted and integrated. Western therapeutic contexts provide different frameworks. The cultural container matters because it determines the interpretive lens through which difficult or profound experiences are understood. Entering a session without any framework for understanding what might happen is a setting deficit, even if the physical environment is optimal.

Nature vs. Indoor Settings

Natural settings — forests, gardens, beaches, mountain environments — tend to produce richer visual and sensory experiences under psilocybin and are often reported as deeply connecting. However, nature settings introduce safety variables absent from indoor settings: changing weather, encounters with other people, physical hazards, and the difficulty of returning inside if needed. For first-time or moderate-dose experiences in natural settings, a fully enclosed natural space (a private garden, a forest with familiar terrain and no public access) is preferable to genuinely open natural environments.

Music as Part of the Setting

Music is not a peripheral element — it is a core component of the setting in essentially all clinical psilocybin research and is widely used in non-clinical guided contexts. The evidence base for music in psilocybin sessions includes:

  • A 2021 study (Barrett et al., Journal of Psychopharmacology) found that music intensity during psilocybin sessions correlated with mystical experience and emotional catharsis
  • Clinical trial playlists (Johns Hopkins, Imperial College, NYU) are systematically designed to follow a narrative arc: gentle opening, gradual build through onset, sustained instrumental peak music during peak effects, and quieter resolve music during the comedown
  • Lyrics tend to be avoided during peak because verbal content is processed with unusual literalness under psilocybin, and lyrical meaning can intrude disruptively on internal processing
  • Silence can become uncomfortable during peak — music provides an emotional container and pacing structure

The Johns Hopkins psilocybin session playlist has been made publicly available on Spotify and is a reasonable starting point for those designing their own setting. Avoid music associated with negative emotional memories. Avoid music with strong associations to other people, which tends to surface relational content at inopportune moments. Classical, ambient, world music, and high-quality film scores tend to work well across populations.

Digital and Phone Policies During Sessions

Most clinical protocols and experienced practitioners recommend a clear policy on devices before sessions begin: phones off or silenced and out of reach. The reasons are evidence-informed:

  • Unexpected messages or notifications introduce unpredictable emotional content at a moment when the capacity to contextualize is reduced
  • Screen light is jarring to visually altered perception; outdoor lighting and candles are preferable to screens
  • The compulsive checking behavior associated with smartphones conflicts with the inward-directed, undistracted attention that produces the most meaningful psilocybin experiences
  • Attempts to document the experience in real-time (texting, photographing) tend to interrupt rather than enhance integration — journaling after the experience is more effective

Practical arrangement: designate a sober contact who has your sitter's number and can be reached in emergencies. Leave that number with the sitter. Then place your phone in a drawer or car for the duration.

Optimizing Set and Setting for Different Contexts

Solo Experiences

Solo experiences carry higher risk than guided or sitter-supported ones, particularly for first-time or high-dose sessions. If choosing a solo experience: use a lower dose (1–2g dried mushrooms for first solo experience), ensure the physical space is as safe as possible, have a safety contact who knows where you are and can check in at a scheduled time, and have a specific plan for what to do if anxiety escalates (lie down, focus on breathing, put on prepared music, remind yourself "this is the psilocybin, it will pass").

Guided and Clinical Contexts

In guided contexts, set preparation focuses more on the relationship with the guide and less on controlling the immediate physical environment. Pre-session meetings (usually 2–3 sessions in clinical trials, or at minimum one extended conversation with a guide) are where intention-setting, expectation-calibration, and relationship-building occur. In clinical settings, the physical environment is pre-designed. The participant's primary set work is arriving with honest self-knowledge, clear intentions, and a willingness to trust the guide and the process.

Set Preparation

Techniques for mental and emotional preparation: intention-setting practices, meditation, addressing anxieties, what to do in the days before.

Prepare Your Mind

Setting Preparation

Step-by-step guide to creating a safe, comfortable, and supportive physical environment — from furniture arrangement to music selection.

Prepare Your Space

Ideal Settings

Optimal settings for different experience types: home, nature, retreat centers, and clinical environments — with specific considerations for each.

Explore Settings

Goal-Specific Setup

Tailoring set and setting for therapeutic, creative, spiritual, or harm-reduction goals — the factors that matter differ by intention.

Match Your Goals

Common Set and Setting Errors

Set Errors

  • Fixed agenda: Entering with a specific outcome you need to achieve. Psilocybin tends to go where it will, not where you direct it. Resistance to unexpected content is a primary cause of difficult experiences.
  • Unprocessed acute trauma without support: Beginning a session while in the middle of a crisis or freshly destabilized without appropriate professional support. Psilocybin will tend to surface and amplify acute emotional material.
  • Concealed contraindicated history: Not disclosing personal or family history of psychosis or mania to a guide or screening team. This hides critical safety-relevant information.
  • Wrong motivation: Using psilocybin primarily as an escape from rather than engagement with difficult material. Avoidance-motivated use tends to be less effective and more anxiety-producing.
  • Impaired baseline: Entering a session significantly sleep-deprived, hungover, on substances that interact pharmacologically, or physically ill. All impair capacity and add variables.

Setting Errors

  • Unknown or unfamiliar space: Taking psilocybin in an environment you have never been in and cannot evaluate for safety — hotel rooms, strangers' homes, public spaces.
  • Unsupportive or unsafe people: Presence of people you don't fully trust, people with their own agenda for your experience, or people who are also dosing and cannot provide sober support.
  • Uncontrolled interruption risk: Sessions where unexpected arrivals, phone calls, or responsibilities cannot be avoided.
  • Night-time without experience: Darkness amplifies disorientation and can amplify fear. First-time or moderate-dose experiences are generally safer in daylight.
  • No plan for difficulty: Entering without a prepared response to challenging experiences — a specific plan for what to do if anxiety escalates substantially reduces the probability that anxiety becomes unmanageable.

The Research Finding on Set and Setting

Research on psilocybin experience outcomes consistently finds that non-pharmacological factors — the broad category encompassing set and setting — account for substantial variability in experience quality, sometimes more than dose. This does not mean dose doesn't matter; it means that optimizing set and setting can produce better outcomes at a given dose than optimizing dose while neglecting set and setting. Preparation is not optional — it is part of the intervention.

Frequently Asked Questions

What does 'set and setting' mean in psychedelic use?

'Set' refers to mindset — the user's expectations, intentions, emotional state, psychological history, and mental health baseline going into the experience. 'Setting' refers to the physical and social environment: the space, the people present, the music, the lighting, and the broader cultural context. Both are considered equally important in determining whether a psilocybin experience is safe, meaningful, and positive. The concept was formalized by Timothy Leary, Alpert, and Metzner in 1964 and has been confirmed by contemporary neuroscience through the REBUS model.

Why is set and setting so important neurologically?

The REBUS (Relaxed Beliefs Under Psychedelics) model developed by Carhart-Harris and Friston explains this mechanistically. Psilocybin suppresses the brain's top-down predictive filtering — the system that normally gates incoming sensory and emotional information through existing expectations. With this filtering reduced, both internal state (set) and external environment (setting) exert greater influence on experience than in ordinary consciousness. This makes set and setting pharmacologically relevant, not merely psychologically. Fear in the set passes through the loosened filter with amplified effect. Beauty in the setting does the same.

What is the ideal setting for a psilocybin session?

An ideal setting is private, physically safe, familiar or made familiar in advance, aesthetically calm, and with controlled access. Key elements: soft lighting (not harsh overhead), comfortable furniture to lie on, a blanket and pillow, access to water and light food, outdoor access if possible, curated music, and ideally a trusted sober person present. Remove or secure anything that could cause physical harm. Clinical trials use specially designed rooms with soft furniture, natural elements, artwork, and headphones — this is a useful model for non-clinical arrangements.

How should I prepare my mindset before a psilocybin experience?

The most evidence-informed preparation approach involves: clarifying intentions as questions rather than demands; practising meditation, journaling, or mindfulness in the days before to develop access to internal states; resolving acute stressors or conflicts where possible; avoiding substances that alter mood (including alcohol and cannabis) for at least 24 hours before; and arriving with a disposition of curiosity and acceptance rather than control. Research from the Griffiths protocol found that spiritual openness and positive expectancy are among the strongest predictors of mystical experience quality.

Should phones be allowed during a psilocybin session?

Most clinical protocols and experienced practitioners recommend placing phones out of reach before sessions begin. Unexpected notifications introduce unpredictable emotional content at a moment when contextualization is impaired. Screen light is visually jarring. Compulsive checking behavior interrupts the inward-directed attention that produces meaningful experiences. Practical alternative: designate a sober contact who has the sitter's number and inform both parties they can reach each other. Place your phone in a drawer or another room for the session duration.

What are seasonal or time-of-day considerations for set and setting?

Daylight is generally preferable for first or moderate-dose experiences — darkness amplifies disorientation and can amplify fear for inexperienced users. Starting mid-morning allows the 4–6 hour peak to resolve before nightfall. Seasonal factors affect available natural light, outdoor access, and temperature comfort. Winter indoor sessions require more careful physical setting design to compensate for limited natural light and outdoor access. Night sessions tend to be more visually intense and introspective — they require considerably more experience and preparation to navigate comfortably.